🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A Paradigm Shift? Contemporary Review of Percutaneous Management for High-Risk Pulmonary Embolism Jay Giri Eric Secemsky MD MSc Duane Pinto MD MPH #thrombosis #embolism #ACCFIT #AHAJournals ahajrnls.org/3mazoAa

Great case this AM using Inari, now part of Stryker FlowTriever to remove extensive clot (R>L) burden in a patient with submassive PE (which resulted in an immediate improvement in hemodynamics!) 🩸💉🩻 Arif Jivan, MD, PhD

Do not miss this chat with Dr. Tu in VTE: A Paradigm Shift On How To Treat Blood Clots. … iheart.com/podcast/1300-t…

#FLAME had primary endpt in-hospital composite of all cause mortality, bailout, deterioration & mj bleeding, and was compared to meta-analytic performance goal (along w a context arm w “other” treatments like lysis)

#FLAME RESULTS PUBLISHED! The largest prospective study of interventional treatment in high-risk #pulmonaryembolism shows 1.9% all-cause in-hospital mortality for patients treated with #FlowTriever. More: bit.ly/45B64Ug

We’re excited to announce that Inari Medical has agreed to acquire #LimFlow, a medical device company focused on transforming the treatment of CLTI, an advanced stage of peripheral artery disease. We look forward to welcoming LimFlow to the #InariMedical family! Read more here:

“In 2023, we still have patients that walk into an office and are given zero options and they end up with their leg gone." 👊🏾👍🏾BT Fisher Sr., MD Vincent Eric Secemsky MD MSc #VIVA2023 tctmd.com/news/dire-lack…

One of my favorite procedures! A procedure that can resolve/alleviate clinical symptoms almost immediately! An important procedure for all interventionist especially in rural settings#rural #irad#interventionalradiology Aaron Tosso Inari, now part of Stryker Bill Parkhurst, MD @JoyHenningsenMD

Will be a great meeting, with a great atmosphere and all the holiday decorations at the DAC! Amir Kaki, MD Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI Seth Bilazarian, MD Duane Pinto MD MPH Thomas Tu MD herbaronowMD

The beginning of a new era in PE clinical research!

Excellent tweetorial!

Successful Aspiration Thrombectomy of a gigantic RA thrombus. No PE on PA gram at the end of the case. TEE pre & post intervention below 👇 #CardioTwitter #MedTwitter #ACCFIT #Cardiology #EchoFirst Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI Abdallah El Sabbagh Sripal Bangalore BCM Cardiology Aga Khan University Matt Wiisanen, MD, FSCAI, FACC

1/ Stable TO unstable HIGH RISK PE Are we correctly stratifying PE patients and recognizing who needs immediate treatment? How are you assessing them and what time frame are you escalating therapy? What variables are you using? Lets discuss.. #VTE #PE #Cardiotwitter

Recanalization of chronically occluded IVC and iliac veins. I bang my head on the wall for these cases but when you have a success it feels great. Inari, now part of Stryker Medtronic Vascular Health Thomas Tu MD

Not all DVT thrombectomy devices are the same. Compelling real world evidence showing differences in outcomes and resource utilization recently published in JSCAI.

#PEERLESS reveals benefits of large-bore mechanical thrombectomy over catheter-directed thrombolysis for intermediate-risk PE. 🚀 Results presented at #TCT2024 and published in Circulation. ahajournals.org/doi/10.1161/CI… #CardioX #CardioTwitter #CardioEd #CardioResearch Dan Burkhoff MD PhD

We are excited to announce that Inari Medical entered into a definitive agreement to be acquired by Stryker. Joining the Stryker family will allow us to build on our tremendous progress in pioneering an entirely new approach to helping patients with Venous Thromboembolism.